Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLUS Study: Individualized Hydroxychloroquine Dosing in SLE
NCT00413361Phase 4Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2007
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hydroxychloroquine in systemic lupus erythematosus (SLE), sponsored by Assistance publique - Hôpitaux de Paris. Started Jun 2007; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT00413361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00413361.